Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation.
JACC: Heart Failure(2020)
Abstract
Serenelli et al. ([1][1]) investigated the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Data from 2 randomized clinical trials using MRAs were compared with those with
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined